Neuroprotective Effect of Reduced Glutathione on Oxaliplatin-Based Chemotherapy in Advanced Colorectal Cancer: A Randomized, Double-Blind, Placebo-Controlled Trial
Stefano Cascinu(Vita-Salute San Raffaele University), Giuseppina Catalano(Unknown), Giordano Beretta(Humanitas Gavazzeni), Paolo Giordani(University of Genoa), Roberto Labianca(Ospedale Papa Giovanni XXIII), Emilio Ubiali(Azienda Ospedaliero-Universitaria delle Marche), L. Cordella(Azienda Ospedaliero-Universitaria delle Marche), Anna Maria Baldelli(Azienda Ospedaliero-Universitaria delle Marche), Vincenzo Catalano(Azienda Ospedaliero-Universitaria delle Marche)
Cited by 416
Related Papers
ESMO Consensus Guidelines for management of patients with colon and rectal cancer. A personalized approach to clinical decision making
|Annals of Oncology|2012|1.5k
Gastric cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up
|Annals of Oncology|2022|1.4k
Localised colon cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
|Annals of Oncology|2020|1.3k
Adjuvant Chemotherapy After Potentially Curative Resection of Metastases From Colorectal Cancer: A Pooled Analysis of Two Randomized Trials
|Journal of Clinical Oncology|2008|582
DNA Mismatch Repair Status and Colon Cancer Recurrence and Survival in Clinical Trials of 5-Fluorouracil-Based Adjuvant Therapy
|JNCI Journal of the National Cancer Institute|2011|527